Christian P. Stevenson, Ph.D.

Christian-Stevenson

Christian P. Stevenson, Ph.D.

Patent Agent

Boston | One International Place, 40th Floor, 100 Oliver Street, Boston, MA 02110-2605
+1 617 654 7134 | +1 617 426 6567

| vCard | PDF

Christian P. Stevenson, Ph.D. is a patent agent in the Patent Counseling and Prosecution practice of Dechert’s Intellectual Property group. Dr. Stevenson assists clients with patent application drafting and prosecution in the U.S. and internationally, freedom-to-operate analyses and intellectual property due diligence. He has experience across a broad range of technologies, including pharmaceuticals, medical devices, drug delivery technologies, chemical processes, biomaterials, agrochemicals and cosmetics.

In addition to his legal experience, Dr. Stevenson is also an accomplished research scientist, having conducted medicinal chemistry and pre-clinical drug discovery at Merck & Co., Inc.  He designed and synthesized novel compounds targeting ion channels, g-protein-coupled receptors and soluble enzymes as potential treatments for diabetes and pain. This work is the subject of numerous issued patents and patent applications.

Dr. Stevenson’s doctoral research focused on the total synthesis of peloruside A, as well as synthetic and mechanistic investigations of the hydrolytic kinetic resolution of terminal epoxides. His research on this subject has been published in peer-reviewed journals, including Journal of the American Chemical Society, Angewandte Chemie and Organic Syntheses.

Prior to joining Dechert, Dr. Stevenson was a scientific advisor at Goodwin Procter and a director of client services at open-innovation and crowdsourcing company, InnoCentive.

Experience
  • Lycera Corporation, a pharmaceutical company developing medicines to treat autoimmune disease and cancer, to manage intellectual property matters including development and implementation of strategies to procure patent protection for multiple small molecule therapeutic agents in human clinical trials.
  • Centrexion Therapeutics Corporation, a pharmaceutical company developing medicines to treat pain, to manage intellectual property matters including development and implementation of strategies to procure patent protection for multiple small molecule therapeutic agents in human clinical trials.
  • Rafael Pharmaceuticals, Inc., a pharmaceutical company developing medicines to treat cancer, to manage intellectual property matters including development and implementation of strategies to procure patent protection for small molecule therapeutic agents being developed for treatment of cancer.

Includes matters handled at Dechert or prior to joining the firm.

Education
  • Wake Forest University, B.S., Chemistry and German, 1999, summa cum laude
  • Harvard University, Ph.D., Organic Chemistry, 2005, National Science Foundation Graduate Research Fellowship, Certificate of Distinction in Teaching
Admissions
  • United States Patent and Trademark Office
Memberships
  • American Chemical Society